{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:36:05Z","timestamp":1783488965437,"version":"3.55.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7302","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T22:52:32Z","timestamp":1346799152000},"page":"2285-2290","source":"Crossref","is-referenced-by-count":39,"title":["Short-Term Effects of \u03b2-adrenergic Antagonists and Methimazole in New-Onset Thyrotoxicosis Caused by Graves' Disease"],"prefix":"10.2169","volume":"51","author":[{"given":"Tetsuya","family":"Tagami","sequence":"first","affiliation":[{"name":"Clinical Research Institute, Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yambe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Mie Chuou Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Mie Chuou Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ogo","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Yoshizumi","sequence":"additional","affiliation":[{"name":"Department of Metabolism and Endocrinology, National Hospital Organization Kyushu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kaise","sequence":"additional","affiliation":[{"name":"Department of General Medicine, National Hospital Organization Sendai Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichiro","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, National Hospital Organization Kumamoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makito","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, National Hospital Organization Kokura Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Shimazu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Usui","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"3. Ramsay I. Adrenergic beta-receptor blockade in hyperthyroidism. Br J Clin Pharmacol 2: 385-388, 1975.","DOI":"10.1111\/j.1365-2125.1975.tb00545.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-1-4-411"},{"key":"3","doi-asserted-by":"crossref","unstructured":"5. Aro A, Huttunen JK, Lamberg BA, et al. Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy for hyperthyroidism. Acta Endocrinol (Copenh) 96: 321-327, 1981.","DOI":"10.1530\/acta.0.0960321"},{"key":"4","doi-asserted-by":"crossref","unstructured":"6. Hellman R. Kelly KL, Mason WD. Propranolol for thyroid storm. N Engl J Med 297: 671-672, 1977.","DOI":"10.1056\/NEJM197709222971222"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7. Kvetny J, Frederikesen PK, Jacobsen JG, Haas V, Feldt-Rasmussen U, Date J. Propranolol in the treatment of thyrotoxicosis. A randomized double-blind study. Acta Med Scand 209: 389-392, 1981.","DOI":"10.1111\/j.0954-6820.1981.tb11613.x"},{"key":"6","unstructured":"9. Agabegi SS, Agabegi ED. Step-Up to Medicine. Hagerstwon, MD. Lippincott Williams & Wilkins, 2008: 59."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2135"},{"key":"8","unstructured":"11. Treatment with, anti-thyroid drugs. Guideline for the treatment of Graves' disease 2011. Japan Thyroid Association, Ed. Nankodo, Tokyo, 2011: 41-67."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00096-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"14. Utiger RD. Beta-adrenergic-antagonist therapy for hyperthyroid Graves' disease. N Engl J Med 310: 1597-1598, 1984.","DOI":"10.1056\/NEJM198406143102410"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90533-J"},{"key":"13","doi-asserted-by":"crossref","unstructured":"16. Wartofsky L. Dimond RC, Noel GL. Frantz AG, Earll JM. Failure of propranolol to alter thyroid iodine release, thyroxine turnover, or the TSH and PRL responses to thyrotropin-releasing hormone in patients with thyrotoxicosis. J Clin Endocrinol Metab 41: 485-490, 1975.","DOI":"10.1210\/jcem-41-3-485"},{"key":"14","doi-asserted-by":"crossref","unstructured":"17. Adlerberth A. Persson S, Hansson G, Hasselgren P. Protein synthesis and quantitative morphology in thyroid tissue from hyperthyroid patients after pre- operative treatment with antithyroid or β-adrenergic antagonist drugs. J Clin Endocrinol Metab 67: 663-668, 1988.","DOI":"10.1210\/jcem-67-4-663"},{"key":"15","doi-asserted-by":"crossref","unstructured":"18. Hadden DR, Bell TK, McDevitt DG, Shanks RG, Montgomery DAD, Weaver JA. Propranolol and the utilization of radioiodine by the human thyroid gland. Acta Endocrinol (Copenh) 61: 393-399, 1969.","DOI":"10.1530\/acta.0.0610393"},{"key":"16","doi-asserted-by":"crossref","unstructured":"19. Kallner G, Ljunggren JG, Tryselius M. The effect of propranolol on serum levels of T4, T3 and reverse-T3 in hyperthyroidism. Acta Med Scand 204: 35-37, 1978.","DOI":"10.1111\/j.0954-6820.1978.tb08394.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"20. Lumholtz IB, Busch-Sorensen M, Faber J. Friis T, Kirkegaard C, Siersback-Nielsen K. The influence of propranolol on the extrathyroidal metabolism of 3.3',5'-triiodothyronine (reverse T3). Acta Med Scand Suppl 624: 31-34, 1979.","DOI":"10.1111\/j.0954-6820.1979.tb00715.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"21. Heyma P, Larkins RG, Higgenbotham L, Ng KW. D-propranolol and dl-propranolol both decrease conversion of l-thyroxine to l-triiodothyronine. Br Med J 281: 24-26, 1980.","DOI":"10.1136\/bmj.281.6232.24"},{"key":"19","doi-asserted-by":"crossref","unstructured":"22. Wiersinga WM, Touber JL. The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine. J Clin Endocrinol Metab 45: 293-298, 1977.","DOI":"10.1210\/jcem-45-2-293"},{"key":"20","doi-asserted-by":"crossref","unstructured":"23. Saunders J, Hall SE, Crowther A, Sönksen PH. The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis. Clin Endocrinol (Oxf) 9: 67-72, 1978.","DOI":"10.1111\/j.1365-2265.1978.tb03573.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/17\/51_51.7302\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:43:53Z","timestamp":1621446233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/17\/51_51.7302\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":20,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7302","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}